A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China
Recruiting now
Conditions studied: Breast Neoplasms
In brief
1. To construct a prospective, multi-center breast cancer treatment cohort in China, and analyze the factors affecting breast cancer diagnosis and treatment. 2. To evaluate the diagnosis and treatment and prognosis of breast cancer among patients in different regions and hospitals.
Key facts
- Study ID
- NCT06591039
- Run by
- Fudan University
- People needed
- 20000
- Starts
- 2022-07-01
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2024-09-19
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with malignant breast tumors must be diagnosed by cytology or histology, and their pathological types include but are not limited to breast carcinoma in situ, invasive carcinoma, and breast sarcoma.
You may not qualify if…
- None
Where it is running
- Cancer Hospital/ Institute, Fudan University — Shanghai, Shanghai Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.